Showing 251-260 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Targeting type 1 Diabetes through Polyamines with DFMO Trustees of Indiana University Emily Sims Cures 01-October-2022 to 30-September-2027 $3,693,701.00
Role of ZBED3 in beta cell stress response and vulnerability against autoimmunity Trustees of Indiana University Erica Cai Cures 01-June-2026 to 29-February-2028 $383,433.16
Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes Trustees of Indiana University Jamie Felton Cures 01-February-2026 to 31-January-2029 $682,534.00
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153,000.00
Design of Pump-Compatible Insulin-Glucagon Fusion Proteins Trustees of Indiana University Michael Weiss Improving Lives 01-April-2026 to 31-March-2027 $255,749.24
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900,000.00
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1,603,777.39
Engineering regulatory B cells to promote immune tolerance for islet cell replacement therapy: A novel opportunity to cure Type I diabetes Trustees of the University of Pennsylvania James Markmann Cures 01-October-2026 to 30-September-2029 $598,995.17
Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs Trustees of the University of Pennsylvania Ji Lei Cures 01-June-2025 to 31-May-2027 $749,999.08
A bioelectronics platform to standardize SC-islet maturation and model T1D autoimmunity Trustees of the University of Pennsylvania Juan Alvarez Cures 01-October-2026 to 30-September-2029 $1,049,999.94